Axial VC
Venture capitalSan Francisco Β· Pre-SeedβSeries A Β· 2 people tracked
Investment thesis
Invests in early-stage life sciences companies, often backing founders when they are no more than an idea.
Team Β· 2 people
from the firm's website
Joshua Elkington is a long-term agency partner to inventors and founder-scientists, specializing in life-sciences company formation at the life sciences/computer science intersection, and publishes biotech strategy on Substack and podcast.
What they invest in
from 26 of 53 portfolio companiesBiotech Γ20AI & Machine Learning Γ12Healthtech Γ11Deep Tech Γ10Medical Devices Γ7Digital Health Γ4Wellness & Fitness Γ4Consumer Γ2
HQs:United StatesΓ17AustraliaΓ1SwitzerlandΓ1
Investments Β· 53 tracked
founders shown can be your intro pathTilda Research provides AI-powered teammates designed to streamline clinical trial operations for sponsors, contract research organizations, and research sites by automating data management and workflow processes.
AI & Machine LearningHealthtechMedical Devices
Ram Yalamanchili(Founder/CEO)
Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials.
AI & Machine LearningBiotechDeep TechHealthtechLausanne, CH
Julian Englert(Founder)inDaniel Nakhaee-Zadeh Gutierrez(Founder)inRobert KapturGerard AntounSam Burns
Aperiam Bio uses computational methods to identify stabilizing mutations in proteins, producing variants with improved expression, solubility, and activity for applications in technical reagents, cosmetics, and pulmonary therapeutics.
AI & Machine LearningBiotechDeep Tech
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
AI & Machine LearningBiotechMedical Devices
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Executive Officer, Director)Steve Kafka(Director)Vineeta Agarwala(Director)Robert Chess(Director)
BoardFrancisco Gimenez(Director)
Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
David Lin(Founder)inBrian Maurer(Founder)inShivam Patel(Founder)in
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Concerto develops microbial ecology data and AI tools to engineer microbe-based products for consumer health applications including skincare, chronic disease, and nutrition.
AI & Machine LearningBiotechDeep TechCambridge, US
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)inDylan Morris(Director)in
Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.
AI & Machine LearningBiotechData & Infrastructure
Glyphic Biotechnologies develops ProSEβ’, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh HaimsoninBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)inBenjamin Edward Birnbaum(Executive Officer, Director)Joshua Daniel Haimson(Executive Officer, Director)Rohan Edward Ganesh(Director)
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.
AI & Machine LearningBiotechMedical Devices
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)Toby Passioura(CSO)Glen McIntyre(COO)
FODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities.
BiotechConsumerFoodTechHealthtechWellness & FitnessBoston, US
Wellness & FitnessLos Angeles, US
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
A drug discovery company advancing novel medicines targeting unexplored areas of immune biology, with a focus on cancer treatments.
Biotech
BiotechCambridge, US
Aaron Ring(Executive Officer, Director)
BoardVineeta Agarwala(Director)Antoine Yver(Director)Owen Hughes(Director)Greg Verdine(Director)
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
BiotechHealthtechBoston, US
Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs.
BiotechDeep TechHealthtechMedical DevicesSan Diego, US
Ben Shepherd(Founder)inAlice Chen(Founder)inAlice Chen, PhDBen Shepherd, PhD(CEO)
Zeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.
HealthtechMedical DevicesSan Francisco, US
Frequently asked questions
- What stage does Axial VC invest at?
- Axial VC invests at the Pre-Seed, Seed, Series A stages.
- What is Axial VC's typical check size?
- Axial VC typically writes checks of $100K β $5M.
- What sectors does Axial VC focus on?
- Axial VC focuses on AgTech, AI & Machine Learning, Biotech, FoodTech, Healthtech, Medical Devices.
- Where is Axial VC located?
- Axial VC is headquartered in San Francisco, US.
- Does Axial VC lead rounds?
- Axial VC typically participates in rounds rather than leading them.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Artesian is a full-stack venture capital firm that leverages extensive regional and global networks to source and invest in early- and growth-stage startups across its key sectors.